There is a link between COVID-19 and overactive bladder (OAB) symptoms, however, the exact mechanisms of this link are not clear. People with COVID-19 have a higher risk of developing urinary symptoms ...
It’s estimated around 3% of people in the UK experience long COVID – persistent, long-lasting symptoms after a COVID-19 infection. Long COVID encompasses a range of health problems that can begin ...
Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...
Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results